OTRA

OTR Acquisition (OTRA)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:OTRA
DataOraFonteTitoloSimboloCompagnia
13/02/202319:45Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:OTRAOTR Acquisition Corporation
31/05/202214:01Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:OTRAOTR Acquisition Corporation
20/05/202222:38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OTRAOTR Acquisition Corporation
20/05/202214:00Business WireComera Life Sciences Debuts as Publicly Traded Company Focused on Transforming BiologicsNASDAQ:OTRAOTR Acquisition Corporation
19/05/202222:08Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:OTRAOTR Acquisition Corporation
18/05/202215:29Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OTRAOTR Acquisition Corporation
17/05/202215:55Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:OTRAOTR Acquisition Corporation
13/05/202222:36Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:OTRAOTR Acquisition Corporation
13/05/202213:17Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:OTRAOTR Acquisition Corporation
09/05/202214:00Business WireComera Life Sciences Announces Research Collaboration with Top 10 Pharmaceutical Company to Develop Subcutaneous FormulationNASDAQ:OTRAOTR Acquisition Corporation
27/04/202214:00Business WireComera Life Sciences to Present at 18th Annual PEGS Boston Conference & ExpoNASDAQ:OTRAOTR Acquisition Corporation
19/04/202214:00Business WireComera Life Sciences and Intas Pharmaceuticals Announce Research CollaborationNASDAQ:OTRAOTR Acquisition Corporation
18/04/202214:00Business WireComera Life Sciences and OTR Acquisition Corp. Announce Effectiveness of Registration Statement for Proposed Business CombinationNASDAQ:OTRAOTR Acquisition Corporation
15/04/202218:05Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (definitive) (defm14a)NASDAQ:OTRAOTR Acquisition Corporation
08/03/202222:08Edgar (US Regulatory)Annual Report (10-k)NASDAQ:OTRAOTR Acquisition Corporation
08/03/202222:02Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:OTRAOTR Acquisition Corporation
18/02/202222:38Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:OTRAOTR Acquisition Corporation
04/02/202214:00Business WireOTR Acquisition Corp. Announces Confidential Submission of S-4 Registration Statement Related to Proposed Business CombinationNASDAQ:OTRAOTR Acquisition Corporation
31/01/202214:32Business WireComera Life Sciences to Become Publicly Traded via Business Combination with OTR Acquisition Corp.NASDAQ:OTRAOTR Acquisition Corporation
06/08/202122:16Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:OTRAOTR Acquisition Corporation
17/05/202122:11Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:OTRAOTR Acquisition Corporation
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:OTRA
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network